Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5628_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
16 Мб
Скачать
☆
4.3.4 Dynamic Stability 132
4.3.4.1 Brownian motion 132
4.3.4.2 Sedimentation and sedimentation equilibrium 133
4.3.4.3 Interparticle interactions 134
4.3.5 Thermodynamic Stability 136
4.3.5.1 Electrical double layer theory and zeta potential 137
4.3.5.2 Electrolyte 138
4.3.5.3 DLVO theory 140
4.3.5.4 Stability in aqueous system 142
4.3.5.5 Impact of polymer compounds on stability 145
4.4 NPP of Inorganic Particles 146
4.4.1 Properties of Inorganic Nanoparticles 146
4.4.1.1 Electronic and optical properties 146
  7    8
4.4.1.4 Thermal properties 148
4.4.2 Biological Application of Inorganic Nanoparticles 149
4.4.2.1 Au nanoparticles 149    2
4.4.2.3 Quantum dots 153
4.4.2.4 Carbon nanotubes 154   4
4.5 Summary and Perspective 155
5. Nano Physical Pharmaceutics of Nanogel Delivery System 161
Xiaoling Pan, Jing Liu, Xiangling Gu, Na Fan, Wan Sun, and Wei Li
    1
5.2 Preparation of Nanogels 162
x
Contents
4.3.3.2 Control of growth phases 130
5.2.2 Chemical Cross-Linking Reaction 163
   5
    tion 165
5.3.1 Cross-Linking of Nanogel 166
5.3.1.1 Gelation theory of nonlinear polycondensation 166
5.3.1.2 Free radical addition polymerization 167
5.3.2 Properties of Polyelectrolyte Nanogels 168
5.3.3 Structure and Stability of Nanogel 169
5.4 NPP of Nanogels in Drug Delivery 170
5.4.1 Physiochemical Properties of Nanogels 170
5.4.1.1 Expansion of nanogels 171
5.4.1.2 Swelling mechanism 172
    
swelling 174
    
of nanogels 175
5.4.2 In vivo Circulation of Nanogels 176
5.4.3 Drug Release Behavior of Nanogels 178
     
Drug-Loaded Nanogels 180
5.4.4.1 Drug-loading methods 181
   2
5.4.4.3 Solvent 182
5.4.4.4 Particle size 183
5.4.4.5 Surface charge 183
5.4.5 Drug Release Behavior of Stimulus-Responsive Nanogels 184
5.4.5.1 Temperature-responsive nanogels 185
5.4.5.2 pH-responsive nanogels 186
5.4.5.3 Glucose-responsive nanogels 186
Contents
xi
    2
5.4.5.4 Photoresponsive nanogels 187
5.4.6 Biological Applications of Nanogel Delivery Systems 188
5.4.6.1 Delivery of small-molecule therapeutic drugs 188
5.4.6.2 Delivery of oligonucleotides 189
5.4.6.3 Delivery of therapeutic proteins 191
5.5 Summary and Perspective 191
6. Nano Physical Pharmaceutics of Microsphere Delivery System 197
Zhiwen Qiu, Wanru Tao, Man Wang, Hanwen Sun, and Wei Li
    7     9
   
 9
6.2.2 Solvent Evaporation 200
6.2.3 Phase Separation 201    1
6.2.5 Spray Drying 202
   3     3
    tion 204
    
DLVO Theory 204
      6      
 8
6.3.3.1 Properties of polymers 208
6.3.3.2 Surface charge of microspheres 210
    1
6.4.1 Physicochemical Properties of  1
xii
Contents
5.4.5.5 Other stimulation-responsive nanogels 188
 9
Contents
xiii
6.4.1.1 Particle size and apparent

Preface

                
improvement, development of novel therapeutic modalities, and reduction in medical expenditures. The challenge, however, is that specially designed and carefully synthesized nanomedicines function poorly in animal models despite great performance in vitro. We believe a deeper understanding of the physico­chemical properties of nanomedicine, that is, nano physical pharmaceutics, is the key.
This book addresses the “bottleneck” of nano-based formulations by focusing on clinical translation and applies physical theories and models to determine the parameters for controlling the physicochemical properties of nanomedicines, including micelles, liposomes, and inorganic nanoparticles. Qualitative and quantitative relationships are established to guide nanomedicine design, characterization, and analysis. The book also compiles cutting-edge research in nanomedicine from the interdisciplinary team of the Department of Nanomedicine at
       
characteristic discipline called Nano Physical Pharmaceutics. Edited by Wei Li, a prominent nanotechnology researcher, this book will appeal to anyone involved in nanotechnology, medicine, macromolecular science, biology, and chemistry, especially those with an interest in drug delivery or cancer therapy. The book has been accomplished with contributions from the team members,
                                   
Duan, Dr Junfang Li, and Dr. Hanwen Sun.
The guidance from Prof. Chi Wu, Prof. Huiming Hou,
        
Prof. Hao Wang and Prof. Jian Wang and the grant of the National
xvi
Preface
Natural Science Foundation of China, the Program of Shanghai Academic Research Leader et al. are appreciated.
        
chemistry, polymer, physicochemistry, biology, and pharmaceutics. The context and the logical illustration of the mechanism of the kinetics and dynamics of polymer chains in solutions have been cited from references. The theory and application of laser light scattering have been cited from the editor’s PhD thesis. Both citations are appreciated [1–3]. However, as some misspellings or other mistakes in the text cannot be ruled out, the readers’ suggestions for any improvements are welcome.
Wei Li
Department of Nanomedicine
Naval Medical University
Shanghai, China
August 2024
References
1. T
eraok a I,
2002.
Press, 2019.
PhD thesis, The Chinese Uni Fu XC, Hou WH,
ceutic
Polymer Solutions
A Concise Textbook of
Reexamination of Dynamic
Physical Chemistr
HM, Wang H, GJ, Technology of Pharma-
al Excipients, 2nd ed., China Medical Science Press, 2002.
versity of Hong K
Zhang
, John
Wiley & Sons, Inc, New York,
Thermodynamics
of Semidilut
y, Higher Education Press, 2022.
, Higher Education
e Polymer Solution,
ong, 2006.
Chapter 1
The Fundamentals and Powerful Tool for Nano Physical Pharmaceutics (NPP)
Ziya Xia, Yening Xia, and Wei Li
Department of Nanomedicine, Naval Medical University, Shanghai 200433, China
liwei_dds@163.com

1.1 Polymer Chains Behavior in Solutions

For a certain polymer, some solvents (good solvents) dissolve it well, some solvents (bad solvents) cannot, and solvents whose solubility is between the good and bad solvents will dissolve it to a certain extent. With the variation of temperature or concentration of the polymers, phase separation may take place, resulting in aggregation of the polymers. In this section, we will introduce the compatibility theory of polymers-solvent, as well as the self-assembly mechanism of polymers.

1.1.1 Basic Interaction of Polymer Chain in Solution

[1–3]
1.1.1.1 Introduction to the c parameter
From the viewpoint of thermodynamics, if the polymers are soluble in solvents, the dissolution process must reduce the free energy of
Nano Physical Pharmaceutics
Edited by Wei Li Copyright © 2025 Jenny Stanford Publishing Pte. Ltd.
ISBN 978-981-4968-52-2 (Hardcover), 978-1-003-51393-3 (eBook)
www.jennystanford.com
2
The Fundamentals and Powerful Tool for Nano Physical Pharmaceutics
the system. The free energy of mixing of the system is as follows [1]:
DGm = DHm – TDS
m
(1.1)
where DGm is the free energy of mixing of the system, DHm is the enthalpy of mixing of the system, DSm is the entropy of mixing of the system and T is the absolute temperature. The change of enthalpy of the system comes from the interaction change upon mixing. Note that only short-ranged interactions are considered here, containing van der Walls interactions (also referred to as dispersions), hydrogen bonding, and dipole-dipole interactions. The change of entropy is because the order of the system changes. Since dissolution is always a process of entropy increasing (DSm > 0), the enthalpy of mixing determines the sign of the free energy of the system, that is, either the enthalpy of the system decreases (DHm < 0) due to dissolution, or the product of temperature and entropy of mixing must be larger than the enthalpy of mixing, then dissolution occurs. Compared with the low-molecular-weight solutes, the degree of freedom of the polymer monomer is lower, so the increase of entropy of mixing is far less than that of the low-molecular-weight solutes­solvent system and the compatibility of the polymers-solvent system will be much lower. The solvents dissolving a certain polymer are only that which surround the polymer chain.
Flory–Huggins parameter, i.e., c parameter, is commonly used to describe the interaction change upon mixing of polymer– solvent system. A lot of solubility theories are based on the        c parameter using the lattice model which considers the interaction between adjacent ones only is described below [2, 3]. The lattice model only considers interactions resulting from the contacts of adjacent molecules in the sites. As shown in Fig. 1.1, the interactions for a polymer–polymer (P–P) contact (i.e., contact of adjacent polymer monomers), a solvent–solvent (S–S) contact, and a polymer–solvent (P–S) contact are represented by ePP, e
SS
and ePS, respectively. Due to the rearrangement of contacts as polymers are mixed with the solvent, the total interaction energy changes.
3
Polymer Chains Behavior in Solutions
For example, there are four P–P and four S–S contacts in respective lattice sites of the polymers and solvent before mixing, while after mixing, two P–P and two S–S contacts are replaced by four P–S contacts. Thus, the bond energy changes from 4e
SS
+ 4e
PP
to 4e
PS
+
2e
SS
+ 2e
PP
and the variation is 4e
PS
– 2(e
SS
+ ePP). For one contact,
the variation is e
PS
– (e
SS
+ ePP)/2. Then, c  product of the lattice coordinate Z and the energy change reduced by kBT:
1
Z e (+e e )
PS PP SS
2
(1.2)
c =
kT
B
A negative c indicates that polymer–solvent contact is more likely to occur when mixing, meaning that a negative c can promote the polymer to dissolve. In contrast, A positive one
       
the polymer–polymer and solvent–solvent contacts.
Figure 1.1 Scheme describes the basic interacons of polymers in soluon.
1.1.1.2 Relationship between c parameter and stability of
the solution [2, 3]
In order to describe the stability of polymer solutions, the concept of replacement chemical potential (D m
rep
) is introduced. Replacement chemical potential is the change of the free energy due to the removal of solvent molecules and the replacement of